en · de · es · fr · pt
aod-9604-notes.peptides6155.com › News › Identity And Research Context — Field Notes

Identity And Research Context — Field Notes

By Editorial Desk · published 2026-02-23 · last reviewed 2026-03-12 · News

The short version of RP-HPLC fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2026-03-12 and is reviewed periodically as new material appears.

Identity and Research Context

Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.

Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.

AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.

Handling And Analytical Properties

Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.

AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.

Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.

Aod-9604 at a glance

PropertyValueNotes
Common nameAOD-9604Development code used in scientific literature.
Chemical classSynthetic peptideFragment of human growth hormone.
Amino acid length16 residuesMatches hGH region 176-191.
AppearanceWhite to off-white powderTypical lyophilized peptide solid.
SolubilitySoluble in waterDissolves in aqueous media; exact behavior depends on salt form.

Background And Research Context

In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.

AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.

Related pages on this site

Handling, Analysis, and Quality Control

Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.

AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.

Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.

Regulatory and Analytical Context

Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.

In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.

Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.

Further detail

Jellyfish-form hydrozoans have evolved many times, including the Portuguese man-o' war, and the crystal jelly. In the evolution of sexual reproduction and origin of the sex chromosome: mammals, females have two copies of the X chromosome (XX) and males have one copy of the X and one copy of the Y chromosome (XY). In birds it is the opposite, with males have two copies of the Z chromosome (ZZ) and females have one copy of the Z and one copy of the W chromosome (ZW). Multicellular organisms arose independently in brown algae (seaweed and kelp), plants, animals, and fungi. Origins of teeth have happened at least two times. Winged flight is found in unrelated species: birds, bats (mammal), insects, pterosaur and Pterodactylus (reptiles). Flying fish do not fly, but are very good at gliding flight. Hummingbird, dragonfly and hummingbird hawk-moth can hover and fly backwards. Neuroglobins are found in vertebrate neurons, (deuterostomes), and are found in the neurons of unrelated protostomes, like photosynthesis acoel and jelly fish. Siphonophorae and Praya dubia resemble and act like jellyfish, but are Hydrozoa, a colony of specialized minute individuals called zooids. Salp, a chordate, also is very much like jellyfish, yet completely different. Eusociality colonies in which only one female (queen) is reproductive and all other are divided into a castes system, all work together in a coordinate system.

== Other uses == The ground product can be called masa nixtamalera. In Central American and Mexican cuisine, masa nixtamalera is cooked with water and milk to make a thick, gruel-like beverage called atole. When made with chocolate and sugar, it becomes atole de chocolate. Adding anise and piloncillo to this mixture creates champurrado, a popular breakfast drink.

The internal phylogeny of the cephalopods is difficult to constrain; many molecular techniques have been adopted, but the results produced are conflicting. Nautilus tends to be considered an outgroup, with Vampyroteuthis forming an outgroup to other squid; however in one analysis the nautiloids, octopus and teuthids plot as a polytomy. Some molecular phylogenies do not recover the mineralized coleoids (Spirula, Sepia, and Metasepia) as a clade; however, others do recover this more parsimonious-seeming clade, with Spirula as a sister group to Sepia and Metasepia in a clade that had probably diverged before the end of the Triassic. Molecular estimates for clade divergence vary. One 'statistically robust' estimate has Nautilus diverging from Octopus at 415 ± 24 million years ago.

Medullary cystic disease Bartter syndrome Diuretic phase of acute tubular necrosis Some diuretics Primary renal diseases Congenital adrenal hyperplasia Syndrome of inappropriate antidiuretic hormone hypersecretion Endogenous natriuretic hormones include:

Relative to SARMs, supraphysiological doses of testosterone (300–600 mg/week intramuscular testosterone enanthate) over similar timeframes, like 20 weeks, have been found to result in lean body mass gains of 5 to 8 kg in healthy young men. In addition to selectivity for muscle and bone over the prostate gland, LGD-4033 has also been stated by Ligand Pharmaceuticals researchers to have reduced strength in the sebaceous glands. Reduced activity in stimulating sebaceous gland formation, to about 30 to 50% of that produced by DHT at doses with similar anabolic potency in rats, has also been reported for certain other SARMs, like the steroidal agents TFM-4AS-1 and MK-0773. In addition, enobosarm and MK-0773 have been reported to limitedly stimulate the sebaceous glands in small short-term clinical studies in women.

Sources: en.wikipedia.org

Supporting material

Modified GRF (1-29) often abbreviated as mod GRF (1-29), originally known as tetrasubstituted GRF (1-29), is a term used to identify a 29 amino acid peptide analogue of growth-hormone-releasing hormone (GHRH), a releasing hormone of growth hormone (GH). It is a modified version of the shortest fully functional fragment of GHRH, often referred to as growth hormone releasing factor (1-29) (abbreviated as GRF (1-29)), and also known by its standardized name, sermorelin.

hemizygous In a diploid organism, having just one allele at a given genetic locus (where there would ordinarily be two). Hemizygosity may be observed when only one copy of a chromosome is present in a normally diploid cell or organism, or when a segment of a chromosome containing one copy of an allele is deleted, or when a gene is located on a sex chromosome in the heterogametic sex (in which the sex chromosomes do not exist in matching pairs); for example, in human males with normal chromosomes, almost all X-linked genes are said to be hemizygous because there is only one X chromosome and few of the same genes exist on the Y chromosome.

== Metabolism == β-Alanine can undergo a transamination reaction with pyruvate to form malonate-semialdehyde and L-alanine. The malonate semialdehyde can then be converted into malonate via malonate-semialdehyde dehydrogenase. Malonate is then converted into malonyl-CoA and enter fatty acid biosynthesis. Alternatively, β-alanine can be diverted into pantothenic acid and coenzyme A biosynthesis.

=== Tangential trapezoid === If the incircle is tangent to the sides AB and CD at W and Y respectively, then a tangential quadrilateral ABCD is also a trapezoid with parallel sides AB and CD if and only if

== Applications == LPC was first suggested as a human food in the early 20th century, but it has not achieved much success, despite early promise. Norman Pirie, the Copley Medal winner from the UK, studied LPC and promoted its use for human consumption. He and his team developed machines for extraction of LPC, including low-maintenance "village units" intended for poor rural communities. These were installed in places such as villages in south India. The non profit organization, Leaf for Life, maintains a list of human edible leaves and provides recommendations for the top choices of plants. There has recently been an interest in using LPCs as an alternative food (or resilient food) during times of catastrophe or food shortages. Such resilient food LPCs would be derived from widely geographically dispersed tree leaves from forests or agricultural waste. LPC have been evaluated for infant weaning foods. The increasing reliance on feedlot based animal rearing to satisfy human appetites for meat has increased demand for cheaper vegetable protein sources. This has recently led to renewed interest in LPC to reduce the use of human-edible vegetable protein sources in animal feed. Leaf protein has had successful trials as a substitute for soy feed for chickens and pigs. LPC from alfalfa can be included in feed for tilapia as a partial replacement for fish meal.

Sources: en.wikipedia.org

Supporting material

== In viruses == Adsorption is the beginning of viral entry, which is the earliest stage of infection in the viral life cycle. The next steps are penetration, uncoating, synthesis (transcription if needed, and translation), and release. The virus replication cycle, in this respect, is similar for all types of viruses. Factors such as transcription may or may not be needed if the virus is able to integrate its genomic information in the cell's nucleus, or if the virus can replicate itself directly within the cell's cytoplasm.

Russia claimed that a Ukrainian drone attack set fire to energy infrastructure in Smolensk Oblast. A drone struck an industrial area in Lipetsk Oblast without details on injuries or damage caused, while an oil refinery was also struck in Voronezh Oblast, causing a fire. Ukrainian sources claimed that some 26,000 cubic metres of fuel was destroyed. The Ukrainian government issued a decree banning the delivery of identification documents and passports to Ukrainian men of military age abroad. The SBU formally announced that Metropolitan Arsenii, the UOC-MP head of the Sviatohirsk Lavra in Donetsk Oblast, was under suspicion of spying for Russia for divulging Ukrainian military positions during a public liturgy. Ukraine received another tranche of 1.5 billion euros in funds from the EU. President Biden signed into law the aid package for Ukraine. The US Department of Defense subsequently announced a $1 billion package that included HIMARS systems, artillery rounds, air defense missiles and Bradley IFVs. A Russian court ordered the seizure of $439.5 million in funds from JPMorgan Chase to recoup losses from US sanctions.

A notation has been developed for indicating peptide fragments that arise from a tandem mass spectrum. Peptide fragment ions are indicated by a, b, or c if the charge is retained on the N-terminus and by x, y or z if the charge is maintained on the C-terminus. The subscript indicates the number of amino acid residues in the fragment. Prime symbols indicate the number of protons or hydrogens added to the fragment to form the observed ion. For example, y'' denotes the singly charged ion analogous to a protonated peptide, (y''')2+ is a doubly charged ion analogous to a doubly protonated peptide.

== History == The concept was first established in the late eighties by Dr. Michael D. West. Dr. West has, through collaboration with Geron, Inc. later funded work in Judith Campisi's lab to create a cell-based screen for drugs that inhibit the phenotype. Campisi subsequently named the phenotype SASP.

==== The Congress of Vienna ==== After Napoleon's defeat, a new European order was established at the Congress of Vienna, which met in the years 1814 and 1815. Adam Jerzy Czartoryski, a former close associate of Emperor Alexander I, became the leading advocate for the Polish national cause. The Congress implemented a new partition scheme, which took into account some of the gains realized by the Poles during the Napoleonic period. The Duchy of Warsaw was replaced in 1815 with a new Kingdom of Poland, unofficially known as Congress Poland. The residual Polish kingdom was joined to the Russian Empire in a personal union under the Russian tsar and it was allowed its own constitution and military. East of the kingdom, large areas of the former Polish–Lithuanian Commonwealth remained directly incorporated into the Russian Empire as the Western Krai. These territories, along with Congress Poland, are generally considered to form the Russian Partition. The Russian, Prussian, and Austrian "partitions" are informal names for the lands of the former Commonwealth, not actual units of administrative division of Polish–Lithuanian territories after partitions. The Prussian Partition included a portion separated as the Grand Duchy of Posen. Peasants under the Prussian administration were gradually enfranchised under the reforms of 1811 and 1823. The limited legal reforms in the Austrian Partition were overshadowed by its rural poverty. The Free City of Cracow was a tiny republic created by the Congress of Vienna under the joint supervision of the three partitioning powers.

Sources: en.wikipedia.org

Frequently asked questions

What is AOD-9604?

AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.

Is AOD-9604 the same as human growth hormone?

No. It contains only a small portion of the human growth hormone sequence. The full hormone has 191 amino acids and many additional actions that the fragment does not share.

Why is it called hGH fragment 176-191?

The name refers to the amino acid positions in the human growth hormone chain. The fragment spans residues 176 through 191 at the C-terminal end. This naming convention helps distinguish it from full-length hGH.

How should AOD-9604 be stored?

Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.

Network